Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Suzhou Wuzhong Biomedical Industrial Park Investment is the investment and operating entity behind the LifeBay biomedical industrial park in Suzhou's Wuzhong district. Rather than being a drug developer, it functions as a healthcare-focused industrial park operator, investment vehicle, and innovation ecosystem builder supporting biotech, medtech, and related service companies. The park promotes innovative therapeutics including antibody-drug conjugates, nucleic acid medicines, protein degradation, cell and gene therapies, antibodies, small molecules, as well as high-value medical devices and AI-enabled healthcare. It also appears to manage or participate in a dedicated biomedical industry fund and provides capital, park infrastructure, and enterprise management support to portfolio and tenant companies. For a biotech analyst, this is best understood as a life-science infrastructure and investment platform, not a standalone therapeutic pipeline company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Suzhou Wuzhong Biomedical Industrial Park.